Stocktoria
USANA HEALTH SCIENCES INC USNA
NYSE · XNYS · stock · Medicinal Chemicals & Botanical Products · website · IPO 1993-10-28
USANA HEALTH SCIENCES INC financials (annual, from 10-K)
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $925.3M | $854.5M | $921.0M | $998.6M | $1.2B |
| Gross profit | $724.4M | $693.3M | $744.3M | $804.7M | $968.6M |
| R&D expense | $10.7M | $11.6M | $11.4M | $11.6M | $11.1M |
| SG&A expense | $337.4M | $263.3M | $257.0M | $262.3M | $279.1M |
| Operating income | $37.4M | $66.3M | $93.1M | $107.6M | $170.2M |
| Interest expense | — | — | $262,000 | $192,000 | $57,000 |
| Income tax | $30.1M | $34.3M | $38.7M | $39.3M | $54.1M |
| Net income | $10.8M | $42.0M | $63.8M | $69.3M | $116.5M |
| EPS (diluted) | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 |
| Operating cash flow | $22.3M | $61.0M | $70.6M | $103.9M | $121.2M |
| Free cash flow | $8.5M | $50.9M | $56.1M | $93.5M | $108.5M |
| Cash & equivalents | $158.4M | $181.8M | $330.4M | $288.4M | $239.8M |
| Inventory | $102.6M | $69.7M | $61.5M | $67.1M | $98.3M |
| Total assets | $742.9M | $748.2M | $632.8M | $596.5M | $577.7M |
| Total liabilities | $156.6M | $161.9M | $135.6M | — | — |
| Shareholders' equity | $533.1M | $532.1M | $497.2M | $434.5M | $395.1M |
Source: SEC EDGAR filings · CIK 0000896264 · as of 2026-01-03. Facts from filings plus Stocktoria's own computed scores — not investment advice.